0.00Open0.00Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover0.00%IV-468.18%PremiumJan 17, 2025Expiry Date6.18Intrinsic Value100Multiplier-4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
LanzaTech Global Stock Discussion
LanzaTech to Form New Joint Venture and Launch Spin-Out of LanzaX Business, and Appoints Interim CFO of LanzaTech
Tuesday, 21st January at 8:45 pm
Announces intent to spin out and form a growth-oriented joint venture for LanzaX, the Company's differentiated synthetic biology platform, with Tharsis Capital joining as new LanzaX strategic partner to accelerate financing for the synbio development pipeline
Appoints new Interim Chief Financial Officer of LanzaTech to ...
📊⚡️📊
No comment yet